この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1994/4/181 分で読めます
DePuy, Inc.; Premarket Approval of the Rotating Platform Configuration of the New Jersey LCSRegister Total Knee System
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing its approval of the application by DePuy, Inc., Warsaw, IN, for premarket approval, under section 515 of the Federal Food, Drug, and Cosmetic Act (the act), of the Rotating Platform Configuration of the new jersey LCS Total Knee System. After reviewing the recommendation of the Orthopedic and Rehabilitation Devices Panel, FDA's Center for Devices and Radiological Health (CDRH) notified the applicant, by letter of February 24, 1994, of the approval of the application.
情報源の原言語: Federal Register — Health and Human Services原文の発表を開く →